These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27168451)

  • 1. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.
    Banerjee R; Humphries R
    Virulence; 2017 May; 8(4):427-439. PubMed ID: 27168451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
    Miller S; Humphries RM
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):705-17. PubMed ID: 27348447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.
    Wong D; Spellberg B
    Virulence; 2017 May; 8(4):383-390. PubMed ID: 27187821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?
    Richter SS; Marchaim D
    Virulence; 2017 May; 8(4):417-426. PubMed ID: 27813699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.
    Kelly AM; Mathema B; Larson EL
    Int J Antimicrob Agents; 2017 Aug; 50(2):127-134. PubMed ID: 28647532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection.
    Lutgring JD; Limbago BM
    J Clin Microbiol; 2016 Mar; 54(3):529-34. PubMed ID: 26739152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
    Trecarichi EM; Tumbarello M
    Virulence; 2017 May; 8(4):470-484. PubMed ID: 28276996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
    Chea N; Bulens SN; Kongphet-Tran T; Lynfield R; Shaw KM; Vagnone PS; Kainer MA; Muleta DB; Wilson L; Vaeth E; Dumyati G; Concannon C; Phipps EC; Culbreath K; Janelle SJ; Bamberg WM; Guh AY; Limbago B; Kallen AJ
    Emerg Infect Dis; 2015 Sep; 21(9):1611-6. PubMed ID: 26290955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new selective broth enrichment automated method for detection of carbapenem-resistant Enterobacteriaceae from rectal swabs.
    Arena F; Giani T; Antonelli A; Colavecchio OL; Pecile P; Viaggi B; Favilli R; Rossolini GM
    J Microbiol Methods; 2018 Apr; 147():66-68. PubMed ID: 29524455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.
    Mortensen JE; DeBurger B; Powell EA; DiFranco-Fisher J; Koeth L; Weissman SJ
    J Glob Antimicrob Resist; 2016 Dec; 7():141-144. PubMed ID: 27835839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three cases of OXA-48-like carbapenemase producing Enterobacteriaceae (not) detected using Xpert
    Boelens J; Yusuf E; Decruyenaere J; Coorevits L; Piérard D; Claeys G
    Acta Clin Belg; 2017 Aug; 72(4):242-244. PubMed ID: 27362624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of screening methods, rates and policies for the detection of carbapenemase-producing Enterobacteriaceae in English hospitals.
    Berry C; Davies K; Woodford N; Wilcox M; Chilton C
    J Hosp Infect; 2019 Feb; 101(2):158-162. PubMed ID: 30092291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan.
    Yamamoto N; Asada R; Kawahara R; Hagiya H; Akeda Y; Shanmugakani RK; Yoshida H; Yukawa S; Yamamoto K; Takayama Y; Ohnishi H; Taniguchi T; Matsuoka T; Matsunami K; Nishi I; Kase T; Hamada S; Tomono K
    J Hosp Infect; 2017 Nov; 97(3):212-217. PubMed ID: 28736270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.
    Neuner EA; Gallagher JC
    Virulence; 2017 May; 8(4):440-452. PubMed ID: 27589330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
    Krapp F; Grant JL; Sutton SH; Ozer EA; Barr VO
    Int J Antimicrob Agents; 2017 Jun; 49(6):770-773. PubMed ID: 28389354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
    Temkin E; Adler A; Lerner A; Carmeli Y
    Ann N Y Acad Sci; 2014 Sep; 1323():22-42. PubMed ID: 25195939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between infection control interventions and carbapenem-resistant Enterobacteriaceae incidence in an endemic hospital.
    Hussein K; Rabino G; Eluk O; Warman S; Reisner S; Geffen Y; Halif L; Paul M
    J Hosp Infect; 2017 Nov; 97(3):218-225. PubMed ID: 28743504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate.
    Salomão MC; Guimarães T; Duailibi DF; Perondi MBM; Letaif LSH; Montal AC; Rossi F; Cury AP; Duarte AJS; Levin AS; Boszczowski I
    J Hosp Infect; 2017 Nov; 97(3):241-246. PubMed ID: 28826688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.